{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:44:35Z","timestamp":1767339875803,"version":"build-2065373602"},"reference-count":134,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Association for Cancer Research","award":["15844"],"award-info":[{"award-number":["15844"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Classic Hodgkin lymphoma is characterized by a few tumor cells surrounded by a protective and immunosuppressive tumor microenvironment (TME) composed by a wide variety of noncancerous cells that are an active part of the disease. Therefore, new techniques to study the cHL-TME and new therapeutic strategies targeting specifically tumor cells, reactivating the antitumor immunity, counteracting the protective effects of the TME, were developed. Here, we describe new methods used to study the cell composition, the phenotype, and the spatial distribution of Hodgkin and Reed\u2013Sternberg (HRS) cells and of noncancerous cells in tumor tissues. Moreover, we propose a classification, with increasing complexity, of the in vitro functional studies used to clarify the interactions leading not only to HRS cell survival, growth and drug resistance, but also to the immunosuppressive tumor education of monocytes, T lymphocytes and fibroblasts. This classification also includes new 3-dimensional (3D) models, obtained by cultivating HRS cells in extracellular matrix scaffolds or in sponge scaffolds, under non-adherent conditions with noncancerous cells to form heterospheroids (HS), implanted in developing chick eggs (ovo model). We report results obtained with these approaches and their applications in clinical setting.<\/jats:p>","DOI":"10.3390\/cancers14102427","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T09:27:56Z","timestamp":1652520476000},"page":"2427","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5352-5677","authenticated-orcid":false,"given":"Naike","family":"Casagrande","sequence":"first","affiliation":[{"name":"Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Borghese","sequence":"additional","affiliation":[{"name":"Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-3566","authenticated-orcid":false,"given":"Donatella","family":"Aldinucci","sequence":"additional","affiliation":[{"name":"Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin Lymphoma","volume":"6","author":"Connors","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ajh.25856","article-title":"Hodgkin Lymphoma: A 2020 Update on Diagnosis, Risk-Stratification, and Management","volume":"95","author":"Ansell","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular Biology of Hodgkin Lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.canlet.2015.10.007","article-title":"Microenvironmental Interactions in Classical Hodgkin Lymphoma and Their Role in Promoting Tumor Growth, Immune Escape and Drug Resistance","volume":"380","author":"Aldinucci","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood.2020005546","article-title":"Rosetting T Cells in Hodgkin Lymphoma Are Activated by Immunological Synapse Components HLA Class II and CD58","volume":"136","author":"Veldman","year":"2020","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-Cell Transcriptome Analysis Reveals Disease-Defining T-Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_7","first-page":"2059","article-title":"The Microenvironmental Niche in Classic Hodgkin Lymphoma Is Enriched for CTLA-4-Positive T Cells That Are PD-1-Negative","volume":"134","author":"Patel","year":"2019","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ejh.12747","article-title":"The Role of Tumour-Infiltrating Eosinophils, Mast Cells and Macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children","volume":"97","author":"Englund","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-Associated Macrophages and Survival in Classic Hodgkin\u2019s Lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3324\/haematol.2015.132761","article-title":"The Immune Microenvironment in Hodgkin Lymphoma: T Cells, B Cells, and Immune Checkpoints","volume":"101","author":"Vardhana","year":"2016","journal-title":"Haematologica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/ejh.12583","article-title":"Tumour-Associated Mast Cells in Classical Hodgkin\u2019s Lymphoma: Correlation with Histological Subtype, Other Tumour-Infiltrating Inflammatory Cell Subsets and Outcome","volume":"96","author":"Andersen","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0394632016644447","article-title":"Role of Mast Cells in Fibrosis of Classical Hodgkin Lymphoma","volume":"29","author":"Nakayama","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bjh.15703","article-title":"High Tumour Plasma Cell Infiltration Reflects an Important Microenvironmental Component in Classic Hodgkin Lymphoma Linked to Presence of B-Symptoms","volume":"184","author":"Gholiha","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fimmu.2020.00398","article-title":"Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma","volume":"11","author":"Hansen","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bankov, K., D\u00f6ring, C., Ustaszewski, A., Giefing, M., Herling, M., Cencioni, C., Spallotta, F., Gaetano, C., K\u00fcppers, R., and Hansmann, M.-L. (2019). Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury. Cancers, 11.","DOI":"10.3390\/cancers11111687"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2014.03.001","article-title":"Mechanisms of Tumor Escape from Immune System: Role of Mesenchymal Stromal Cells","volume":"159","author":"Poggi","year":"2014","journal-title":"Immunol. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/leu.2016.232","article-title":"Microenvironmental Interactions between Endothelial and Lymphoma Cells: A Role for the Canonical WNT Pathway in Hodgkin Lymphoma","volume":"31","author":"Linke","year":"2017","journal-title":"Leukemia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/1878-0261.12616","article-title":"High CD206 Levels in Hodgkin Lymphoma-Educated Macrophages Are Linked to Matrix-Remodeling and Lymphoma Dissemination","volume":"14","author":"Arlt","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Aldinucci, D., Borghese, C., and Casagrande, N. (2019). Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It. Int. J. Mol. Sci., 20.","DOI":"10.20944\/preprints201904.0209.v1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological Analysis Reveals a PD-L1-Associated Microenvironmental Niche for Reed-Sternberg Cells in Hodgkin Lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood-2017-09-772632","article-title":"Biology of Classical Hodgkin Lymphoma: Implications for Prognosis and Novel Therapies","volume":"131","author":"Mottok","year":"2018","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1182\/blood.V85.3.780.bloodjournal853780","article-title":"Expression of Functional CD40 Antigen on Reed-Sternberg Cells and Hodgkin\u2019s Disease Cell Lines","volume":"85","author":"Carbone","year":"1995","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2326-6066.CIR-17-0325","article-title":"Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma","volume":"5","author":"Wein","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.2019000568","article-title":"An Etiological Role for the Epstein-Barr Virus in the Pathogenesis of Classical Hodgkin Lymphoma","volume":"134","author":"Murray","year":"2019","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/ijc.30473","article-title":"The Impact of EBV and HIV Infection on the Microenvironmental Niche Underlying Hodgkin Lymphoma Pathogenesis","volume":"140","author":"Carbone","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1182\/blood-2013-04-499004","article-title":"The EBV Oncogene LMP1 Protects Lymphoma Cells from Cell Death through the Collagen-Mediated Activation of DDR1","volume":"122","author":"Cader","year":"2013","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2353\/ajpath.2008.070845","article-title":"Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin\u2019s Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells","volume":"173","author":"Baumforth","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21037\/aol-21-8","article-title":"The Contribution of Ebv to the Pathogenesis of Classical Hodgkin Lymphoma","volume":"5","author":"Vrzalikova","year":"2021","journal-title":"Ann. Lymphoma"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Navarro, J.-T., Molt\u00f3, J., Tapia, G., and Ribera, J.-M. (2021). Hodgkin Lymphoma in People Living with HIV. Cancers, 13.","DOI":"10.20944\/preprints202108.0420.v1"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/modpathol.2012.217","article-title":"Spindle-Shaped CD163+ Rosetting Macrophages Replace CD4+ T-Cells in HIV-Related Classical Hodgkin Lymphoma","volume":"26","author":"Hartmann","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood.2020009178","article-title":"Brentuximab Vedotin in Combination with Nivolumab in Relapsed or Refractory Hodgkin Lymphoma: 3-Year Study Results","volume":"138","author":"Advani","year":"2021","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/bloodadvances.2021004511","article-title":"Avelumab in Relapsed\/Refractory Classical Hodgkin Lymphoma: Phase 1b Results from the JAVELIN Hodgkins Trial","volume":"5","author":"Herrera","year":"2021","journal-title":"Blood Adv."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1182\/bloodadvances.2021005304","article-title":"Adoptive T-Cell Therapy for Hodgkin Lymphoma","volume":"5","author":"Ho","year":"2021","journal-title":"Blood Adv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1200\/JCO.20.01342","article-title":"Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma","volume":"38","author":"Ramos","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"775599","DOI":"10.3389\/fcell.2021.775599","article-title":"Humanized CD30-Targeted Chimeric Antigen Receptor T Cells Exhibit Potent Preclinical Activity Against Hodgkin\u2019s Lymphoma Cells","volume":"9","author":"Guo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/1078-0432.CCR-18-1133","article-title":"Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3K\u03b4\/\u03b3 Inhibitor RP6530","volume":"25","author":"Locatelli","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2020.12.015","article-title":"Trabectedin Overcomes Doxorubicin-Resistance, Counteracts Tumor-Immunosuppressive Reprogramming of Monocytes and Decreases Xenograft Growth in Hodgkin Lymphoma","volume":"500","author":"Casagrande","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1158\/1078-0432.CCR-19-1768","article-title":"Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma","volume":"26","author":"Chen","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A View on Drug Resistance in Cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1535-7163.MCT-16-0408","article-title":"Mechanisms of Resistance to Antibody-Drug Conjugates","volume":"15","author":"Loganzo","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1158\/1078-0432.CCR-19-4137","article-title":"A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models","volume":"26","author":"Wei","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Honor\u00e9, B., Andersen, M.D., Wilken, D., Kamper, P., d\u2019Amore, F., Hamilton-Dutoit, S., and Ludvigsen, M. (2022). Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling. Cancers, 14.","DOI":"10.3390\/cancers14010247"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","article-title":"Spatial Omics and Multiplexed Imaging to Explore Cancer Biology","volume":"18","author":"Lewis","year":"2021","journal-title":"Nat. Methods"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"aaf6925","DOI":"10.1126\/sciimmunol.aaf6925","article-title":"In-Depth Tissue Profiling Using Multiplexed Immunohistochemical Consecutive Staining on Single Slide","volume":"1","author":"Remark","year":"2016","journal-title":"Sci. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2014.08.016","article-title":"Multiplexed Immunohistochemistry, Imaging, and Quantitation: A Review, with an Assessment of Tyramide Signal Amplification, Multispectral Imaging and Multiplex Analysis","volume":"70","author":"Stack","year":"2014","journal-title":"Methods"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"672531","DOI":"10.3389\/fmolb.2021.672531","article-title":"Tissue Multiplex Analyte Detection in Anatomic Pathology - Pathways to Clinical Implementation","volume":"8","author":"Wharton","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"668340","DOI":"10.3389\/fmolb.2021.668340","article-title":"Methods to Determine and Analyze the Cellular Spatial Distribution Extracted From Multiplex Immunofluorescence Data to Understand the Tumor Microenvironment","volume":"8","author":"Parra","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e31657","DOI":"10.7554\/eLife.31657","article-title":"Highly Multiplexed Immunofluorescence Imaging of Human Tissues and Tumors Using T-CyCIF and Conventional Optical Microscopes","volume":"7","author":"Lin","year":"2018","journal-title":"Elife"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/PAS.0000000000000242","article-title":"A Single Slide Multiplex Assay for the Evaluation of Classical Hodgkin Lymphoma","volume":"38","author":"Lazare","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1038\/s41467-021-24822-1","article-title":"Subcellular Localization of Biomolecules and Drug Distribution by High-Definition Ion Beam Imaging","volume":"12","author":"Jiang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1021\/ac901049w","article-title":"Mass Cytometry: Technique for Real Time Single Cell Multitarget Immunoassay Based on Inductively Coupled Plasma Time-of-Flight Mass Spectrometry","volume":"81","author":"Bandura","year":"2009","journal-title":"Anal. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","article-title":"Multiplex Digital Spatial Profiling of Proteins and RNA in Fixed Tissue","volume":"38","author":"Merritt","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/978-1-4939-9773-2_25","article-title":"High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-Oncology Biomarker Discovery and Translational Research","volume":"2055","author":"Beechem","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAP.0000000000000263","article-title":"Clinical Application of Image Analysis in Pathology","volume":"27","author":"Cornish","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.mpdhp.2020.07.002","article-title":"Multiplex Immunohistochemistry in Lymphoma Pathology: A Research Tool for Study of the Immune Microenvironment","volume":"26","author":"Pugh","year":"2020","journal-title":"Diagn. Histopathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin Lymphoma with Reduced \u03922M\/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2018-99-115434","article-title":"Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyxTM Hyperplexed Immunofluorescence Assay in Hodgkin Lymphoma","volume":"132","author":"Au","year":"2018","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jclinpath-2021-207789","article-title":"Gene of the Month: T-Cell Immunoreceptor with Immunoglobulin and ITIM Domains (TIGIT)","volume":"75","author":"Bolm","year":"2022","journal-title":"J. Clin. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Li, W., Blessin, N.C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., and Debatin, N.F. (2018). Expression of the Immune Checkpoint Receptor TIGIT in Hodgkin\u2019s Lymphoma. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-5111-1"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1038\/s41598-021-86655-8","article-title":"A Novel Scoring System for TIGIT Expression in Classic Hodgkin Lymphoma","volume":"11","author":"Annibali","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clml.2020.11.009","article-title":"Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma","volume":"21","author":"Adam","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Karihtala, K., Leivonen, S.-K., Br\u00fcck, O., Karjalainen-Lindsberg, M.-L., Mustjoki, S., Pellinen, T., and Lepp\u00e4, S. (2020). Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma. Cancers, 12.","DOI":"10.3390\/cancers12040877"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00262-019-02464-z","article-title":"Mass Cytometry Defines Distinct Immune Profile in Germinal Center B-Cell Lymphomas","volume":"69","author":"Roussel","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3324\/haematol.2019.243287","article-title":"Whole-Slide Image Analysis of the Tumor Microenvironment Identifies Low B-Cell Content as a Predictor of Adverse Outcome in Patients with Advanced-Stage Classical Hodgkin Lymphoma Treated with BEACOPP","volume":"106","author":"Jachimowicz","year":"2021","journal-title":"Haematologica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-021-01056-8","article-title":"Next Generation of Immune Checkpoint Inhibitors and Beyond","volume":"14","author":"Kimbrough","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12094-019-02171-2","article-title":"Expression of CD47 Antigen in Reed-Sternberg Cells as a New Potential Biomarker for Classical Hodgkin Lymphoma","volume":"22","author":"Villegas","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gholiha, A.R., Hollander, P., L\u00f6f, L., Glimelius, I., Hedstrom, G., Molin, D., Hjalgrim, H., Smedby, K.E., Hashemi, J., and Amini, R.-M. (2022). Checkpoint CD47 Expression in Classical Hodgkin Lymphoma. Br. J. Haematol., 1\u201310.","DOI":"10.1111\/bjh.18137"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1158\/1078-0432.CCR-20-3706","article-title":"Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies","volume":"27","author":"Ansell","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Opinto, G., Agostinelli, C., Ciavarella, S., Guarini, A., Maiorano, E., and Ingravallo, G. (2021). Hodgkin Lymphoma: A Special Microenvironment. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204665"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1158\/1078-0432.CCR-19-2356","article-title":"A Gene Expression\u2013Based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma Patients","volume":"26","author":"Luminari","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1182\/blood.2021011941","article-title":"A Gene Expression-Based Model Predicts Outcome in Children with Intermediate-Risk Classical Hodgkin Lymphoma","volume":"139","author":"Johnston","year":"2022","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/s41375-021-01314-1","article-title":"Gene Expression-Based Outcome Prediction in Advanced Stage Classical Hodgkin Lymphoma Treated with BEACOPP","volume":"35","author":"Jachimowicz","year":"2021","journal-title":"Leukemia"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Bertuzzi, C., Sabattini, E., and Agostinelli, C. (2021). Immune Microenvironment Features and Dynamics in Hodgkin Lymphoma. Cancers, 13.","DOI":"10.3390\/cancers13143634"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","article-title":"Mass Cytometry of Hodgkin Lymphoma Reveals a CD4+ Regulatory T-Cell-Rich and Exhausted T-Effector Microenvironment","volume":"132","author":"Cader","year":"2018","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.2711","article-title":"The Classical Hodgkin\u2019s Lymphoma Microenvironment and Its Role in Promoting Tumour Growth and Immune Escape","volume":"221","author":"Aldinucci","year":"2010","journal-title":"J. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2009-03-209650","article-title":"T Lymphocytes Coexpressing CCR4 and a Chimeric Antigen Receptor Targeting CD30 Have Improved Homing and Antitumor Activity in a Hodgkin Tumor Model","volume":"113","author":"Rooney","year":"2009","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1189\/jlb.0906565","article-title":"Hodgkin\u2019s Reed-Sternberg Cell Line (KM-H2) Promotes a Bidirectional Differentiation of CD4+CD25+Foxp3+ T Cells and CD4+ Cytotoxic T Lymphocytes from CD4+ Naive T Cells","volume":"82","author":"Tanijiri","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3324\/haematol.2018.196725","article-title":"CCR5 Antagonism by Maraviroc Inhibits Hodgkin Lymphoma Microenvironment Interactions and Xenograft Growth","volume":"104","author":"Casagrande","year":"2019","journal-title":"Haematologica"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ijc.23119","article-title":"Expression of CCR5 Receptors on Reed-Sternberg Cells and Hodgkin Lymphoma Cell Lines: Involvement of CCL5\/Rantes in Tumor Cell Growth and Microenvironmental Interactions","volume":"122","author":"Aldinucci","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41408-019-0185-9","article-title":"Reverse Signaling via PD-L1 Supports Malignant Cell Growth and Survival in Classical Hodgkin Lymphoma","volume":"9","author":"Jalali","year":"2019","journal-title":"Blood Cancer J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e1160186","DOI":"10.1080\/2162402X.2016.1160186","article-title":"Tumor-Infiltrating HLA-Matched CD4+ T Cells Retargeted against Hodgkin and Reed\u2013Sternberg Cells","volume":"5","author":"Rengstl","year":"2016","journal-title":"OncoImmunology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00418-014-1244-8","article-title":"Combining Immunofluorescence with in Situ Proximity Ligation Assay: A Novel Imaging Approach to Monitor Protein-Protein Interactions in Relation to Subcellular Localization","volume":"142","author":"Pacchiana","year":"2014","journal-title":"Histochem. Cell Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2011-07-370841","article-title":"High ERp5\/ADAM10 Expression in Lymph Node Microenvironment and Impaired NKG2D Ligands Recognition in Hodgkin Lymphomas","volume":"119","author":"Zocchi","year":"2012","journal-title":"Blood"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.11370","article-title":"Expression of CCL5\/RANTES by Hodgkin and Reed-Sternberg Cells and Its Possible Role in the Recruitment of Mast Cells into Lymphomatous Tissue","volume":"107","author":"Fischer","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1182\/blood.V88.9.3299.bloodjournal8893299","article-title":"Human Eosinophils Express Functional CD30 Ligand and Stimulate Proliferation of a Hodgkin\u2019s Disease Cell Line","volume":"88","author":"Pinto","year":"1996","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/annonc\/8.suppl_2.S89","article-title":"The Role of Eosinophils in the Pathobiology of Hodgkin\u2019s Disease","volume":"8","author":"Pinto","year":"1997","journal-title":"Ann. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-Associated Macrophages as Treatment Targets in Oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"438","DOI":"10.21037\/atm.2016.08.53","article-title":"THP-1 Cells as a Model for Human Monocytes","volume":"4","author":"Bosshart","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Tudor, C.S., Bruns, H., Daniel, C., Distel, L.V., Hartmann, A., Gerbitz, A., and Buettner, M.J. (2014). Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114345"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/2159-8290.CD-16-0850","article-title":"Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells","volume":"7","author":"Ruella","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41375-020-0737-9","article-title":"PD-L1\/L2 Protein Levels Rapidly Increase on Monocytes via Trogocytosis from Tumor Cells in Classical Hodgkin Lymphoma","volume":"34","author":"Kawashima","year":"2020","journal-title":"Leukemia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1083\/jcb.201301081","article-title":"M2-like Macrophages Are Responsible for Collagen Degradation through a Mannose Receptor\u2013Mediated Pathway","volume":"202","author":"Madsen","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9410","DOI":"10.1038\/s41598-020-66010-z","article-title":"Tumor-Associated Macrophages in Classical Hodgkin Lymphoma: Hormetic Relationship to Outcome","volume":"10","author":"Werner","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"100730","DOI":"10.1016\/j.drup.2020.100730","article-title":"Ex Vivo Cultures and Drug Testing of Primary Acute Myeloid Leukemia Samples: Current Techniques and Implications for Experimental Design and Outcome","volume":"53","author":"Cucchi","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood-2011-10-386763","article-title":"PI3K\u03b4 Inhibitor, GS-1101 (CAL-101), Attenuates Pathway Signaling, Induces Apoptosis, and Overcomes Signals from the Microenvironment in Cellular Models of Hodgkin Lymphoma","volume":"119","author":"Meadows","year":"2012","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3389\/fimmu.2018.01358","article-title":"Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype","volume":"9","author":"Reiners","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2015-07-660365","article-title":"Preclinical Activity of the Repurposed Drug Auranofin in Classical Hodgkin Lymphoma","volume":"126","author":"Celegato","year":"2015","journal-title":"Blood"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ijc.24389","article-title":"Functional Coexpression of Interleukin (IL)-7 and Its Receptor (IL-7R) on Hodgkin and Reed-Sternberg Cells: Involvement of IL-7 in Tumor Cell Growth and Microenvironmental Interactions of Hodgkin\u2019s Lymphoma","volume":"125","author":"Cattaruzza","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/10428194.2013.800196","article-title":"Bortezomib Down-Modulates the Survival Factor Interferon Regulatory Factor 4 in Hodgkin Lymphoma Cell Lines and Decreases the Protective Activity of Hodgkin Lymphoma-Associated Fibroblasts","volume":"55","author":"Celegato","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2014.03.030","article-title":"The NF-\u039aB Inhibitor DHMEQ Decreases Survival Factors, Overcomes the Protective Activity of Microenvironment and Synergizes with Chemotherapy Agents in Classical Hodgkin Lymphoma","volume":"349","author":"Celegato","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"737449","DOI":"10.3389\/fcell.2021.737449","article-title":"N Tumor-Derived Extracellular Vesicles: Modulation of Cellular Functional Dynamics in Tumor Microenvironment and Its Clinical Implications","volume":"9","author":"Santos","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41375-020-01104-1","article-title":"Clinical Relevance of Extracellular Vesicles in Hematological Neoplasms: From Liquid Biopsy to Cell Biopsy","volume":"35","author":"Trino","year":"2021","journal-title":"Leukemia"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e1421889","DOI":"10.1080\/2162402X.2017.1421889","article-title":"Specific ADAM10 Inhibitors Localize in Exosome-like Vesicles Released by Hodgkin Lymphoma and Stromal Cells and Prevent Sheddase Activity Carried to Bystander Cells","volume":"7","author":"Tosetti","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e1123367","DOI":"10.1080\/2162402X.2015.1123367","article-title":"ADAM10 New Selective Inhibitors Reduce NKG2D Ligand Release Sensitizing Hodgkin Lymphoma Cells to NKG2D-Mediated Killing","volume":"5","author":"Zocchi","year":"2015","journal-title":"Oncoimmunology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/path.4306","article-title":"Protrusion-Guided Extracellular Vesicles Mediate CD30 Trans-Signalling in the Microenvironment of Hodgkin\u2019s Lymphoma","volume":"232","author":"Hansen","year":"2014","journal-title":"J. Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e12121","DOI":"10.1002\/jev2.12121","article-title":"Extracellular Vesicle MiRNA Predict FDG-PET Status in Patients with Classical Hodgkin Lymphoma","volume":"10","author":"Drees","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Repetto, O., Lovisa, F., Elia, C., Enderle, D., Romanato, F., Buffardi, S., Sala, A., Pillon, M., Steffan, A., and Burnelli, R. (2021). Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence. Diagnostics, 11.","DOI":"10.3390\/diagnostics11060917"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Slyusarenko, M., Shalaev, S., Valitova, A., Zabegina, L., Nikiforova, N., Nazarova, I., Rudakovskaya, P., Vorobiev, M., Lezov, A., and Filatova, L. (2022). AuNP Aptasensor for Hodgkin Lymphoma Monitoring. Biosensors, 12.","DOI":"10.3390\/bios12010023"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3960\/jslrt.21005","article-title":"Significance of Trogocytosis and Exosome-Mediated Transport in Establishing and Maintaining the Tumor Microenvironment in Lymphoid Malignancies","volume":"61","author":"Kawashima","year":"2021","journal-title":"J. Clin. Exp. Hematop."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1781334","DOI":"10.1080\/2162402X.2020.1781334","article-title":"The Role of Trogocytosis in Immune Surveillance of Hodgkin Lymphoma","volume":"9","author":"Zeng","year":"2020","journal-title":"Oncoimmunology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e1160188","DOI":"10.1080\/2162402X.2016.1160188","article-title":"CD137 Signaling in Hodgkin and Reed-Sternberg Cell Lines Induces IL-13 Secretion, Immune Deviation and Enhanced Growth","volume":"5","author":"Rajendran","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e23441","DOI":"10.4161\/onci.23441","article-title":"Ectopic CD137 Expression Facilitates the Escape of Hodgkin and Reed-Sternberg Cells from Immunosurveillance","volume":"2","author":"Pang","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/0008-5472.CAN-12-3849","article-title":"Expression of CD137 on Hodgkin and Reed-Sternberg Cells Inhibits T-Cell Activation by Eliminating CD137 Ligand Expression","volume":"73","author":"Ho","year":"2013","journal-title":"Cancer Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/boc.201800002","article-title":"Trogocytosis of Ligand-Receptor Complex and Its Intracellular Transport in CD30 Signalling","volume":"110","author":"Nakashima","year":"2018","journal-title":"Biol. Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3324\/haematol.2017.178384","article-title":"CD83 Is a New Potential Biomarker and Therapeutic Target for Hodgkin Lymphoma","volume":"103","author":"Li","year":"2018","journal-title":"Haematologica"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Colombo, E., and Cattaneo, M.G. (2021). Multicellular 3D Models to Study Tumour-Stroma Interactions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041633"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Farhat, J., Pandey, I., and AlWahsh, M. (2021). Transcending toward Advanced 3D-Cell Culture Modalities: A Review about an Emerging Paradigm in Translational Oncology. Cells, 10.","DOI":"10.3390\/cells10071657"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.18632\/oncotarget.23156","article-title":"Co-Targeting of Tiam1\/Rac1 and Notch Ameliorates Chemoresistance against Doxorubicin in a Biomimetic 3D Lymphoma Model","volume":"9","author":"Ikram","year":"2018","journal-title":"Oncotarget"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41231-019-0050-7","article-title":"Lost in Translation: The Valley of Death across Preclinical and Clinical Divide \u2013 Identification of Problems and Overcoming Obstacles","volume":"4","author":"Seyhan","year":"2019","journal-title":"Transl. Med. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Pinto, B., Henriques, A.C., Silva, P.M.A., and Bousbaa, H. (2020). Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121186"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3324\/haematol.2021.278469","article-title":"Inhibitors of A Disintegrin And Metalloproteinases-10 Reduce Hodgkin Lymphoma Cell Growth in 3D Microenvironments and Enhance Brentuximab-Vedotin Effect","volume":"107","author":"Pece","year":"2021","journal-title":"Haematologica"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1080\/10428190701573190","article-title":"Three-Dimensional Culturing of the Hodgkin Lymphoma Cell-Line L1236 Induces a HL Tissue-like Gene Expression Pattern","volume":"48","author":"Birgersdotter","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1038\/s41596-021-00615-0","article-title":"Analysis of Clonogenic Growth in vitro","volume":"16","author":"Brix","year":"2021","journal-title":"Nat. Protoc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3324\/haematol.2021.279389","article-title":"In Classical Hodgkin Lymphoma the Combination of the CCR5 Antagonist Maraviroc with Trabectedin Synergizes, Enhances DNA Damage and Decreases Three-Dimensional Tumor-Stroma Heterospheroid Viability","volume":"107","author":"Casagrande","year":"2022","journal-title":"Haematologica"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"30523","DOI":"10.18632\/oncotarget.8864","article-title":"CD30 on Extracellular Vesicles from Malignant Hodgkin Cells Supports Damaging of CD30 Ligand-Expressing Bystander Cells with Brentuximab-Vedotin, in Vitro","volume":"7","author":"Hansen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9440(10)64878-X","article-title":"Expression of Functional Interleukin-3 Receptors on Hodgkin and Reed-Sternberg Cells","volume":"160","author":"Aldinucci","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.trecan.2020.10.009","article-title":"3D In Vitro Model (R)Evolution: Unveiling Tumor\u2013Stroma Interactions","volume":"7","author":"Rodrigues","year":"2021","journal-title":"Trends Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Goncharova, O., Flinner, N., Bein, J., D\u00f6ring, C., Donnadieu, E., Rikirsch, S., Herling, M., K\u00fcppers, R., Hansmann, M.-L., and Hartmann, S. (2019). Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells. Cancers, 11.","DOI":"10.3390\/cancers11101484"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2014-05-576140","article-title":"Reed-Sternberg Cell-Derived Lymphotoxin-\u03b1 Activates Endothelial Cells to Enhance T-Cell Recruitment in Classical Hodgkin Lymphoma","volume":"124","author":"Fhu","year":"2014","journal-title":"Blood"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"112716","DOI":"10.1016\/j.yexcr.2021.112716","article-title":"Chorioallantoic Membrane Vascularization. A Meta-Analysis","volume":"405","author":"Ribatti","year":"2021","journal-title":"Exp. Cell Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/onc.2016.183","article-title":"WNT5A: A Motility-Promoting Factor in Hodgkin Lymphoma","volume":"36","author":"Linke","year":"2017","journal-title":"Oncogene"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/10\/2427\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:10:40Z","timestamp":1760137840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/10\/2427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":134,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["cancers14102427"],"URL":"https:\/\/doi.org\/10.3390\/cancers14102427","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2022,5,14]]}}}